Nguyen TV, Llanes ÁC, Morales CNJ, Hernández OMO

Language: Spanish
References: 30
Page: 30-42
PDF size: 217.68 Kb.

ABSTRACT

Introduction: The Guillain-Barre Syndrome is a frequent cause of generalized acute motor paralysis in children of countries where the poliomyelitis has been eradicated, as Cuba and the western world.
Objective: To characterize the patients with Guillain-Barre Syndrome in the hospital José Luis Miranda.
Material and methods: An observational, descriptive and traverse study was carried out. The universe was constituted by 12 patients.
Results: The represented age group went the one from 4 to 7 years with 50 %. The main infectious antecedents corresponded with high breathing infection (33, 3 %) and infection of the tract urinal (8,3 %). Five patients presented complications and one of these it died.
Conclusions: Most of the patients of the study belonged to the age group from 4 to 7 years, of the masculine sex. The most important infectious antecedents were the high breathing infections. Most of the patients had favorable evolution.

REFERENCES

1. Lestayo–O´Farrill Z, Hernández–Cáceres JL. Análisis del comportamiento del síndrome de Guillain–Barré. Consensos y discrepancias. Rev Neurol. 2008; 46: 230– 7.

2. Cruse RP. Overview of Guillain-Barré syndrome in children. 2007; [citado 23 sept 2013]. Disponible en: URL:http://www.uptodate.com/

3. Bradshaw DY, Jones HR. Pseudo meningoencephalitic presentation of pediatric Guillain-Barré syndrome. J Children Neurol. 2001; 16:505-8.

4. Madrid Rodríguez A. Síndrome de Miller-Fisher asociado a neuropatía axonal motora aguda: correlación clínico-inmunológica. Neurología. 2012; 27(3):179-88.

5. Winer JB. Guillain-Barré syndrome. Revisión clínica. BMJ. 2008; 337:671.

6. Estrada–González JR, Goyenechea A, Herrera C. Brote de polirradiculoneuritis aguda tipo Landry–Guillain–Barré–Ströhl durante una epidemia de dengue. Rev Cub Hig Epidem. 1981; 19:252–65.

7. Asbury AK, Arnason BG, Karp KR, McFarlain DE. Criteria for diagnosis of Guillain Barré syndrome. Ann Neurol. 1978; 28(3):565-6.

8. Asbury AK. New concept of Guillain-Barré syndrome. J Child Neurol. 2000; 15:183- 91.

9. Geleijns K, Brouwer BA, Jacobs BC, Houwing-Duistermaat JJ, van Duijn CM, van Doorn PA. The occurrence of Guillain-Barré syndrome within families. Neurology. 2004; 63:1747-50.

10. Ramírez–Zamora M, Burgos–Ganuza CR, Alas–Valle DA, Vergara–Galán PE, Ortez– González CI. Síndrome de Guillain–Barré en edad pediátrica. Perfil epidemiológico, clínico y terapéutico en un hospital de El Salvador. Rev Neurol. 2009; 48:292–6.

11. Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, et al. S. GD1bspecific antibody induces ataxia in Guillain-Barré syndrome. Neurology. 2008; 71:196-201.

12. Rocha MS, Brucki SM, Carvalho AA, Lima UW. Epidemiologic features of Guillain- Barré syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatric. 2004; 62:33-7.

13. Winner JB. Guillain–Barré syndrome: Clinical variants and their pathogenesis. Journal of Neuroimmunology. 2011; 231:70–72.

14. Kuwabara S. Guillain-Barré syndrome. Curr Neurol Neurosci Rep. 2007; 7:57-62.

15. McCoya B, Kinga M, Gillb D, Twomeyc E. Childhood posterior reversible encephalopathy syndrome. European Journal of Pediatric Neurology. 2011; 15(2):91-94.

16. Arami MA, Yazdchi M, Khandaghi R. Epidemiology and characteristics of Guillain- Barré syndrome in the northwest of Iran. Ann Saudi Med. 2006; 26:22-7.

17. McLean M, Duclos P, Jacob P, Humphreys P. Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-1989,using hospital service data bases. Epidemiology. 1994; 5:443-8.

18. Ferreira R, Boto A, Correia M, Moreno T, Carvalho A, Santos E, et al. Síndrome de Guillain-Barré e hipertermia maligna: uma nova associação? Acta Pediatrica Portuguesa. 2002; 6:449-52.

19. López Jiménez E, Silveira Sánchez D, Ricardo Ojea L. Síndrome de Guillain-Barré en la Unidad de Cuidados Intensivos. Rev 16 de abril. 2010; 241

20. Monteiro JP, Fonseca J, Proenca P, Calhau M, Braga MJ. Síndrome de Guillain- Barré en edad pediátrica. Experiencia de la Unidad de Neuropediatría de un hospital portugués. Rev Neurol. 2006; 42(3):144-149.

21. Torriente Cortina M, Barroso AF, Valdivieso Romero JF. Caracterización del síndrome de Guillain–Barré en el Hospital “Julio Trigo López” durante el período 2000–2009. Rev Cubana Neurol y Neurocir. 2012; 2(1):3–8.

22. Pérez Lledó E, Díaz Vico A, Gómez Gosálvez FA. Síndrome de Guillain-Barré: presentación clínica y evolución en menores de 6 años de edad. An Pediatr (Barc). 2012; 76(2):69-76.

23. Vázquez Vázquez L, Gómez Vargas JR, Candales Arafet LA, Vázquez Drake A. Síndrome de Guillain-Barré-Strohl. Variedad Miller-Fisher. Rev Cubana Med Intens Emerg. 2005; 4(1).

24. Ostia Garza PJ, Fuentes Cuevas MC. Síndrome de Guillain-Barré variedad Miller- Fisher. Reporte de un caso. Arch Inv Mat Inf. 2011; 3(1):30-35.

25. Hughes RA, Raphael JC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Data base Syst Rev. 2009 ;( 2).

26. Kuijf ML, Geleijns K, Ennaji N, van Rijs W, van Doorn PA, Jacobs BC. Susceptibility to Guillain–Barré syndrome is not associated with CD1A and CD1E gene polymorphisms J. Neuroimmunol. 2008; 35(7):49-57.

27. Fernández–Ortega JF, de Rojas–Román JP, Núñez–Castain MJ, Miralles–Martín E, Bravo–Utrera M. Síndrome de Guillain–Barré en Unidad de Cuidados Intensivos. Rev Neurol. 2001; 33:318–24.

28. Visser LH, Schmitz PI, Meulstee J, van Doorn PA, van der Meche FG. Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group. Neurology. 2011; 53:598-604.

29. Sang D, Chen Q, Liu X, Hongdang Q, Daoxiang W, Liang Y, Zhang L. Fc receptor like 3 in Chinese patients of Han nationality with Guillain–Barré syndrome. Journal of Neuroimmunology. 2012; 246(1-2):65–68.

30. Kokubun N. Conduction block and axonal degeneration co-occurring in a patient with axonal Guillain-Barré syndrome. Journal of the Neurological Sciences. 2012; 319(1-2):164-167.